INSPIRE MEDICAL SOLE SOURCE LETTER.docx
DOCX document 271 KB Posted
- Attached to
- INSPIRE THERAPY SYSTEM Federal contract opportunity
- Solicitation number
- N6809422R6022
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| N6809422R6022.pdf | ||
| SOLE SOURCE JUSTIFICATION.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
August 12, 2021
Re: Sole Source Letter
To Whom it may concern:
This letter is to inform you that Inspire Medical Systems, Inc. (“Inspire”) is the sole source of the Inspire therapy system, an implantable nerve stimulator system used to treat moderate to severe obstructive sleep apnea (the “Inspire Therapy System”). The Inspire Therapy System consists of (a) implanted components, including an implantable pulse generator, a stimulation lead, and a sensing lead, and (b) external components, including a physician programmer and a patient programmer.
In the United States, the Inspire Therapy System can only be purchased directly from Inspire. Competition in providing the Inspire Therapy System is precluded by the existence of patent, copyright, and trade secrets. There are no other like products available for purchase that would serve the same purpose or function, and there is only one price for the Inspire Therapy System.
Should you have any questions concerning the foregoing or require additional information, please do not hesitate to contact me.
With kind regards, Bryan K. Phillips Sr. Vice President, General Counsel and Secretary
Inspire Medical Systems, Inc. │ 5500 Wayzata Boulevard, Suite 1600 │ Golden Valley, Minnesota 55416 │ www.inspiresleep.com image1.png image2.jpeg
File details come from the government source that posted it. Updated .